Pharmacology, Toxicology and Pharmaceutical Science
Cannabidiol
100%
Proton Pump Inhibitor
50%
Chronic Disease
50%
Bioavailability
50%
Hyponatremia
50%
Multiple Sclerosis
50%
Polypharmacy
21%
Placebo
16%
Sleep Disorder
16%
Muscle Atrophy
12%
Vitamin D
12%
Inflammation
12%
Pharmacokinetics
8%
Cannabis
8%
Somnolence
8%
Combination Therapy
8%
Prevalence
7%
Cardiovascular Disease
7%
Cognitive Defect
7%
Adverse Outcome
7%
Side Effect
6%
Non-Steroidal Anti-Inflammatory Drug
6%
Microflora
6%
Anti-Inflammatory Drug
6%
Diseases
6%
Medicine and Dentistry
Patient with Chronic Illness
50%
Proton-Pump Inhibitor
50%
Muscle Function
50%
Outpatient
50%
Geriatrics
50%
Magnesium
25%
Polypharmacy
21%
Body Mass Index
14%
Logistic Regression Analysis
14%
Muscle Atrophy
12%
Vitamin D
12%
Chronic Disease
12%
Osteoporosis
7%
Group Sex
7%
Adverse Outcome
7%
Cardiovascular Disease
7%
Bootstrapping
7%
Cognitive Defect
7%
Prevalence
7%
Anti-Inflammatory Drug
6%
Nonsteroid Antiinflammatory Agent
6%
Gut
6%
Gastrointestinal Tract
6%
Diseases
6%
Side Effect
6%
Biochemistry, Genetics and Molecular Biology
Absorption
56%
Proton Pump
50%
Muscle Function
50%
Cannabidiol
50%
Vitamin D
12%
Cannabis Sativa
12%
Anti-Inflammatory
12%
Pharmacokinetics
8%
Gastrointestinal Tract
6%
Microflora
6%
Grand Unified Theory
6%